Variation in Vasoactive Treatment Selection for Cardiogenic Shock: Insights From the Critical Care Cardiology Trials Network (CCCTN)
Related Posts
Nakano H, Kawahira N, Vesprey A, Nakano A. Maternal hyperglycemia disrupts cardiomyocyte maturation via aberrant nucleotide metabolism and suppression of AMPK signaling. Cell Rep. 2026[...]
Turner AC, Li S, Wahab F, Zhao J, Thomas K, Poudel R, Reeves M, Smith EE, Messé SR, Fonarow GC, Schwamm LH, Zachrison KS. National[...]
Whelton SP, Yao J, Clish C, Wood AC, Taylor KD, Blaha MJ, Budoff M, Marrero N, Thanassoulis G, Post WS, Guo X, Rotter JI. Association[...]